1. Home
  2. CRDO vs RGEN Comparison

CRDO vs RGEN Comparison

Compare CRDO & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Credo Technology Group Holding Ltd

CRDO

Credo Technology Group Holding Ltd

HOLD

Current Price

$246.75

Market Cap

50.7B

Sector

Technology

ML Signal

HOLD

Logo Repligen Corporation

RGEN

Repligen Corporation

HOLD

Current Price

$163.83

Market Cap

6.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CRDO
RGEN
Founded
2008
1981
Country
Cayman Islands
United States
Employees
N/A
N/A
Industry
Semiconductors
Medical/Dental Instruments
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
50.7B
6.6B
IPO Year
2022
1995

Fundamental Metrics

Financial Performance
Metric
CRDO
RGEN
Price
$246.75
$163.83
Analyst Decision
Strong Buy
Buy
Analyst Count
14
12
Target Price
$179.62
$167.67
AVG Volume (30 Days)
5.3M
1.3M
Earning Date
06-01-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
765.52
286.96
EPS
2.51
0.24
Revenue
$1,335,116,000.00
$141,236,000.00
Revenue This Year
$210.92
$14.30
Revenue Next Year
$57.22
$14.52
P/E Ratio
$99.56
$682.92
Revenue Growth
205.68
35.10
52 Week Low
$86.49
$100.99
52 Week High
$308.67
$175.77

Technical Indicators

Market Signals
Indicator
CRDO
RGEN
Relative Strength Index (RSI) 52.07 66.63
Support Level $225.66 $156.65
Resistance Level $241.14 $163.24
Average True Range (ATR) 18.44 8.35
MACD 2.60 1.52
Stochastic Oscillator 76.81 91.22

Price Performance

Historical Comparison
CRDO
RGEN

About CRDO Credo Technology Group Holding Ltd

Credo Technology Group Holding Ltd provides connectivity solutions for AI-driven applications, cloud computing, and hyperscale networks. Its high-speed copper and optical interconnect products support data infrastructure demands. The Company's product portfolio includes ZeroFlap (ZF) Active Electrical Cables (AECs), ZF optical transceivers, OmniConnect memory solutions, and retimers and DSPs for optical and copper Ethernet and PCIe, leveraging the PILOT diagnostic and analytics software platform. Its products are based on Serializer/Deserializer (SerDes) and Digital Signal Processor (DSP) technologies and include integrated circuits (ICs), Active Electrical Cables (AECs), SerDes Chiplets, and SerDes IP licensing solutions. The United States generates the maximum revenue.

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category (about 55% of total revenue), while chromatography, proteins, and process analytics are 21%, 11%, and 13%, respectively. Customers in North America, Europe, and Asia Pacific contribute about 44%, 37%, and 19% of revenue, respectively.

Share on Social Networks: